Altered neurotrophism in diabetic neuropathy: Spelunking the caves of peripheral nerve

Journal of Pharmacology and Experimental Therapeutics

Volumn 313, Issue 2, 2005, Pages 485-491

  Dobrowsky, Rick T ^a   Rouen, Shefali ^a   Yu, Cuijuan ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; NEUROTROPHIN; PROTEOME; SOMATOMEDIN;

CAVEOLA; CELL INTERACTION; CELL SUBPOPULATION; CELL SURVIVAL; DIABETES MELLITUS; DIABETIC NEUROPATHY; HUMAN; HYPERGLYCEMIA; MOTONEURON; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROTROPISM; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SCHWANN CELL; SENSORY NERVE CELL; SIGNAL TRANSDUCTION;

ANIMALS; CAVEOLAE; DIABETIC NEUROPATHIES; HUMANS; NERVE GROWTH FACTORS; PERIPHERAL NERVES;

EID: 18044393630     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.079921     Document Type: Review

References (43)

1. Adlkofer K and Lai C (2000) Role of neuregulins in glial cell development. Glia 29:104-111.
2. Apfel SC (1999) Nerve regeneration in diabetic neuropathy. Diabetes Obes Metab 1:3-11.
3. Apfel SC (2002) Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold? Int Rev Neurobiol 50:393-412.
4. Brussee V, Cunningham FA, and Zochodne DW (2004) Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 53:1824-1830.
5. Bucci M, Roviezzo F, Brancaleone V, Lin MI, Di Lorenzo A, Cicala C, Pinto A, Sessa WC, Farneti S, Fiorucci S, et al. (2004) Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression. Arterioscler Thromb Vasc Biol 24:721-726.
6. Carroll SL, Miller ML, Frohnert PW, Kim SS, and Corbett JA (1997) Expression of neuregulins and their receptors, Erb B2 and Erb B3, is induced during Wallerian degeneration. J Neurosci 17:1642-1659.
7. Chen S, Rio C, Ji RR, Dikkes P, Coggeshall RE, Woolf CJ, and Corfas G (2003) Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss. Nat Neurosci 6:1186-1193.
8. Cheng C and Zochodne DW (2002) In vivo proliferation, migration and phenotypic changes of Schwann cells in the presence of myelinated fibers. Neuroscience 115:321-329.
9. Cheng HL, Steinway ML, Russell JW, and Feldman EL (2000) GTPases and phosphatidylinositol 3-kinase are critical for insulin-like growth factor-I-mediated Schwann cell motility. J Biol Chem 275:27197-27204.
10. Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, Scherer PE, and Lisanti MP (2003) Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. 285:C222-C235.
11. Delaney CL, Cheng HL, and Feldman EL (1999) Insulin-like growth factor-I prevents caspase-mediated apoptosis in Schwann cells. J Neurobiol 41:540-548.
12. Dyck PJB and Dyck PJ (1999) Diabetic polyneuropathy, in Diabetic Neuropathy (Dyck PJ and Thomas A eds) pp 255-278, W. B. Saunders, Philadelphia.
13. Engelman JA, Lee RJ, Karnezis A, Bearss DJ, Webster M, Siegel P, Muller WJ, Windle JJ, Pestell RG, and Lisanti MP (1998) Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J Biol Chem 273:20448-20455.
14. Feldman EL, Stevens MJ, Russell JW, and Greene DA (2003) Somatosensory neuropathy, in Diabetes Mellitus (Porte DS, Sherwin RS, and Baron A eds) pp 771-788, McGraw-Hill, New York.
15. Fielding CJ and Fielding PE (2000) Cholesterol and caveolae: structural and functional relationships. Biochim Biophys Acta 1529:210-222.
16. Garratt AN, Voiculescu O, Topilko P, Charnay P, and Birchmeier C (2000) A dual role of erbB2 in myelination and in expansion of the Schwann cell precursor pool. J Cell Biol 148:1035-1046.
17. Gonzalez E, Nagiel A, Lin AJ, Golan DE, and Michel T (2004) siRNA-mediated down-regulation of caveolin-1 differentially modulates signaling pathways in endothelial cells. J Biol Chem 279:40659-40669.
18. Grinspan JB, Marchionni MA, Reeves M, Coulaloglou M, and Scherer SS (1996) Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. J Neurosci 16:6107-6118.
19. Harrisingh MC, Perez-Nadales E, Parkinson DB, Malcolm DS, Mudge AW, and Lloyd AC (2004) The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation. EMBO (Eur Mol Biol Org) J 23:3061-3071.
20. Hellweg R, Raivich G, Hartung HD, Hock C, and Kreutzberg GW (1994) Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy. Exp Neurol 130:24-30.
21. Huang TJ, Price SA, Chilton L, Calcutt NA, Tomlinson DR, Verkhratsky A, and Fernyhough P (2003) Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 52:2129-2136.
22. Huijbregts RPH, Roth KA, Schmidt RE, and Carroll SL (2003) Hypertrophic neuropathies and malignant peripheral nerve sheath tumors in transgenic mice over-expressing glial growth factor β3 in myelinating Schwann cells. J Neurosci 23:7269-7280.
23. Jurevics H and Morell P (1995) Cholesterol for synthesis of myelin is made locally, not imported into brain. J Neurochem 64:895-901.
24. Leinninger GM, Vincent AM, and Feldman EL (2004) The role of growth factors in diabetic peripheral neuropathy. J Peripher Nerv Syst 9:26-53.
25. Maurel P and Salzer JL (2000) Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI 3-kinase activity. J Neurosci 20:4635-4645.
26. Meier C, Dermietzel R, Davidson KGV, Yasumura T, and Rash JE (2004) Connexin 32-containing gap junctions in Schwann cells at the internodal zone of partial myelin compaction and in Schmidt-Lanterman incisures. J Neurosci 24:3186-3198.
27. Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role L, Lai C, Schwab MH, and Nave KA (2004) Axonal neuregulin-1 regulates myelin sheath thickness. Science (Wash DC) 304:700-703.
28. Mikol DD, Hong HL, Cheng HL, and Feldman EL (1999) Caveolin-1 expression in Schwann cells. Glia 27:39-52.
29. Mikol DD, Scherer SS, Duckett SJ, Hong HL, and Feldman EL (2002) Schwann cell caveolin-1 expression increases during myelination and decreases after axotomy. Glia 38:191-199.
30. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature (Lond) 404:787-790.
31. Ogata T, Iijima S, Hoshikawa S, Miura T, Yamamoto S, Oda H, Nakamura K, and Tanaka S (2004) Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination. J Neurosci 24:6724-6732.
32. Pascariu M, Bendayan M, and Ghitescu L (2004) Correlated endothelial caveolin overexpression and increased transcytosis in experimental diabetes. J Histochem Cytochem 52:65-76.
33. Pearson RJ Jr and Carroll SL (2004) ErbB transmembrane tyrosine kinase receptors are expressed by sensory and motor neurons projecting into sciatic nerve. J Histochem Cytochem 52:1299-1311.
34. Pinkas-Kramarski R, Shelly M, Guarino BC, Wang LM, Lyass L, Alroy I, Alimandi M, Kuo A, Moyer JD, Lavi S, et al. (1998) ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network. Mol Cell Biol 18:6090-6101.
35. Purves TD, Middlemas A, Agthong S, Jude EB, Boulton AJM, Fernyhough P, and Tomlinson DR (2001) A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J 15:2508-2514.
36. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, et al. (2001) Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276:38121-38138.
37. Syroid DE, Maycox PR, Burrola PG, Liu N, Wen D, Lee KF, Lemke G, and Kilpatrick TJ (1996) Cell death in the Schwann cell lineage and its regulation by neuregulin. Proc Natl Acad Sci 93:9229-9234.
38. Tan W, Rouen S, Barkus KM, Dremina YS, Hui D, Christianson JA, Wright DE, Yoon SO, and Dobrowsky RT (2003) Nerve growth factor blocks the glucose-induced downregulation of caveolin-1 expression in Schwann cells via p75 neurotrophin receptor signaling. J Biol Chem 278:23151-23162.
39. The Diabetes Control and Complications Trial Research Group (1995) The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 122:561-568.
40. Uittenbogaard A, Everson WV, Matveev SV, and Smart EJ (2002) Cholesteryl ester is transported from caveolae to internal membranes as part of a caveolin-annexin II lipid-protein complex. J Biol Chem 277:4925-4931.
41. Uittenbogaard A, Ying Y, and Smart EJ (1998) Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. J Biol Chem 273:6525-6532.
42. Vincent AM, Russell JW, Low P, and Feldman EL (2004) Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 25:612-628.
43. Zanazzi G, Einheber S, Westreich R, Hannocks MJ, Bedell-Hogan D, Marchionni MA, and Salzer JL (2001) Glial growth factor/neuregulin inhibits Schwann cell myelination and induces demyelination. J Cell Biol 152:1289-1299.